Dishman Pharmaceuticals and Chemicals Limited News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Dishman Pharmaceuticals and Chemicals Limited from all sources in a single place.

Load latest

Dishman Pharmaceuticals and Chemicals Limited

21 Apr 2016, 06:00PM

SAST

Board Intimation for Results & Closure of Trading Window

BSE India

Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that the Board Meeting for considering and taking on record the Audited Financial Result of the Company for the quarter & year ended on March 31, 2016, is scheduled to be held on May 19, 2016.In view of the same and as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window shall...

Dishman Pharmaceuticals and Chemicals Limited

21 Apr 2016, 04:32PM

Company Update

Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Dishman Pharmaceuticals and Chemicals Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015.

pdf

Dishman Pharmaceuticals and Chemicals Limited

15 Apr 2016

Company Update

Shareholding for the Period Ended March 31, 2016

BSE India

Dishman Pharmaceuticals and Chemicals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here

Dishman Pharmaceuticals and Chemicals Limited

15 Apr 2016

Company Update

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March …

BSE India

Dishman Pharmaceuticals and Chemicals Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Dishman Pharmaceuticals and Chemicals Limited

12 Apr 2016

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

BSE India

Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

pdf

Dishman Pharmaceuticals and Chemicals Limited

11 Apr 2016

SAST

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

BSE India

Janmejay R Vyas has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

pdf

Dishman Pharmaceuticals and Chemicals Limited

31 Mar 2016

Company Update

Updates

BSE India

Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that Company has acquired further 50% stake in Schutz Dishman Biotech Ltd., a Joint Venture Indian Company, from the existing JV Partner i.e. SCHUTZ & CO. BETEILIGUNGSGESELLSCHAFT MBH, Germany for a consideration of EURO 300,000.Schutz Dishman Biotech Ltd. (Schutz Dishman), is engaged in the business of manufacturing of Bulk Drugs, Drug formulations and performance Chemicals in...

Dishman Pharmaceuticals and Chemicals Limited

22 Mar 2016

Company Update

Newspaper Advertisement in respect of completion of dispatch of Notice of postal ballot

BSE India

Dishman Pharmaceuticals and Chemicals Ltd has submitted to BSE a copy of Newspaper Advertisement in respect of completion of dispatch of Notice of Postal Ballot.

pdf